Rhythm Pharmaceuticals's total assets for Q1 2025 were $386.69M, a decrease of -1.42% from the previous quarter. RYTM total liabilities were $223.60M for the fiscal quarter, a -1.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.